Drawing for NAVIGO PROTEINS PURE PRECISION

USPTO serial 79264393

NAVIGO PROTEINS PURE PRECISION

Reviewed by CopyMark Law Group

Reg. 6015880Status 709
Filing date
Status date
Registration date
Mar 24, 2020
Examiner
WILKE, JOHN
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NAVIGO PROTEINS PURE PRECISION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adam D. Mandell

Adam D. Mandell Millen, White, Zelano & Branigan, P.C.2200 Clarendon Blvd., Ste 1400Arlington, VA 22201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic, therapeutic, analytical, biological, chemical, biochemical substances, active agents, and/or compositions, namely, diagnostic preparations for medical and veterinary use, therapeutic preparations for medical and veterinary use, pharmaceutical preparations for the medical treatment of cancer, metabolic, inflammatory, skin, eye and cardiovascular diseases, and chemical reagents for medical or veterinary purposesSECTION 71 - CANCELLED—
042Scientific, technological and industrial analysis services and research, in particular in the pharmaceutical, diagnostic, analytical or biochemical field; scientific and technological services and research relating thereto for identification, further development and use of biochemical, pharmaceutical, analytical or diagnostic products; molecular biological, biotechnological, biochemical or pharmaceutical laboratory services; research and development in the field of medical and veterinary diagnostics and treatment using molecular biological, genetic engineering, biotechnological or biochemical methods, and research and development services in the field of identification, screening of pharmaceutically active components, and test methods and test kitsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026C71TCANCELLED SECTION 71—
Mar 24, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 22, 2021INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jan 20, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 26, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 31, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jul 31, 2020XXCRGENERIC MADRID TRANSACTION CREATED—
Jun 24, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 20, 2020COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 13, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 17, 2020ES7RTEAS SECTION 7 REQUEST RECEIVED—
Mar 24, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 7, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 7, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2020GPNXNOTIFICATION PROCESSED BY IB—
Dec 18, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 18, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 18, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 26, 2019PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 13, 2019ALIEASSIGNED TO LIE—
Nov 8, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 8, 2019ATRVATTORNEY REVIEW COMPLETED—
Nov 7, 2019CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Nov 6, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 1, 2019CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 5, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 14, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 13, 2019RFRRREFUSAL PROCESSED BY MPU—
Aug 21, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 18, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 17, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2019DOCKASSIGNED TO EXAMINER—
Aug 17, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 6, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 1, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance